Clinical trial

Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)

NCT06259175

Study summary

ClinicalTrials.gov

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Amlodipine 5 mg + indapamide 1.25 mg + perindopril 5 mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Amlodipine 5 mg + indapamide 2.5 mg + perindopril 10 mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Amlodipine 10 mg + indapamide 2.5 mg + perindopril 10 mg Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2024-05-01

PhaseN/A

Conditions

Arterial Hypertensionunresolved

HTNunresolved

Interventions

Amlodipine 5 mg + indapamide 1.25 mg + perindopril 5 mgDRUG

Amlodipine 5 mg + indapamide 2.5 mg + perindopril 10 mgDRUG

Amlodipine 10 mg + indapamide 2.5 mg + perindopril 10 mgDRUG

Sponsors & collaborators

Servier Russialead sponsor

Mapped research locations

MoscowRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06259175 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.